BEI
TMO icon

Benjamin Edwards Inc’s Thermo Fisher Scientific TMO Stock Holding History

Benjamin Edwards Inc’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.18M Sell
12,323
-52
-0.4% -$25K 0.06% 308
2026
Q1 		$6.08M Sell
12,375
-219
-2% -$119K 0.06% 291
2025
Q4 		$7.3M Buy
12,594
+154
+1% +$87.1K 0.08% 241
2025
Q3 		$6.03M Buy
12,440
+772
+7% +$359K 0.07% 266
2025
Q2 		$4.73M Sell
11,668
-41
-0.4% -$17.1K 0.06% 289
2025
Q1 		$5.83M Sell
11,709
-2,663
-19% -$1.44M 0.08% 234
2024
Q4 		$7.48M Buy
14,372
+284
+2% +$156K 0.11% 205
2024
Q3 		$8.72M Buy
14,088
+11,882
+539% +$7.03M 0.13% 183
2024
Q2 		$1.22M Buy
2,206
+69
+3% +$39.5K 0.23% 116
2024
Q1 		$1.24M Buy
2,137
+420
+24% +$236K 0.25% 110
2023
Q4 		$911K Buy
1,717
+1,497
+680% +$725K 0.2% 138
2023
Q3 		$111K Buy
220
+215
+4,300% +$115K 0.03% 378
2023
Q2 		$3K Sell
5
-131
-96% -$70.7K ﹤0.01% 632
2023
Q1 		$79K Sell
136
-111
-45% -$62.6K 0.02% 399
2022
Q4 		$136K Sell
247
-88
-26% -$46.6K 0.04% 319
2022
Q3 		$170K Sell
335
-75
-18% -$42K 0.05% 269
2022
Q2 		$223K Buy
410
+93
+29% +$51.2K 0.07% 248
2022
Q1 		$187K Buy
317
+91
+40% +$52.3K 0.05% 284
2021
Q4 		$151K Buy
+226
New +$141K 0.05% 292

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Benjamin Edwards Inc's TMO Position: Q2 2026 in Review

Benjamin Edwards Inc reduced its Thermo Fisher Scientific (TMO) stake by 0.42% in Q2 2026, selling an estimated $25K and leaving 12,323 shares worth $6.18M. The position accounts for 0.06% of the portfolio, ranked #308.

Benjamin Edwards Inc first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $8.72M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Benjamin Edwards Inc held 12,323 shares of Thermo Fisher Scientific worth $6.18M as of Q2 2026.
  • Benjamin Edwards Inc sold 52 Thermo Fisher Scientific shares in Q2 2026, an estimated $25K.
  • Thermo Fisher Scientific made up 0.06% of Benjamin Edwards Inc's portfolio in Q2 2026, its #308 holding.
  • Benjamin Edwards Inc first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • Benjamin Edwards Inc's Thermo Fisher Scientific position peaked at $8.72M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.